Katherine Clayton is the co-founder and CEO of OmniVis. Her background in engineering revealed her fervor for combining technology, global health, and user-centered design to make healthcare easily accessible. After a study abroad stint in Thailand, this inspired her to pursue her masters and PhD in biomedical and mechanical engineering, where she developed some of the underlying algorithms that are used in the OmniVis technology. Katherine believes that access to healthcare should be a human right, not a privilege. Outside of OmniVis, Katherine is passionate about travel, modern art, cooking, and reading about science and the history of spacecraft.
Venture: OmniVis uses a revolutionary sensing technique to quantify and analyze biomolecular solutions directly at the source. OmniVis’s easy to use hardware device and consumable test kit attaches to a smartphone and reduces the detection process to 30 minutes, accurately and affordably. Data gathering and reporting tools provide insights over disease hotspots; enabling users to prevent outbreaks before they happen. Founded in 2017, OmniVis is focused on developing devices for use in biotechnology specifically in global health and biotherapeutics.